Effects of intravenous administration of polymyxin B in neonatal foals with experimental endotoxemia

Objective—To evaluate the effect of IV administration of polymyxin B on clinical and serum biochemical variables in foals with experimental endotoxemia. Design—Prospective experimental study. Animals—14 healthy neonatal foals. Procedures—Foals were randomly assigned to a treatment or control group and were administered a single dose of lipopolysaccharide (0.5 μg/kg [0.23 μg/lb]) IV over 30 minutes. The treatment group received polymyxin B (6,000 U/kg [2,727 U/lb], IV) immediately after completion of lipopolysaccharide infusion; the control group was administered an equal volume of saline (0.9% NaCl) solution. Subsequent doses of polymyxin B or saline solution were administered IV at 8 and 16 hours. Blood was collected at various time points, and outcome variables, including heart rate, respiratory rate, rectal temperature, attitude score, WBC count, neutrophil count, lymphocyte count, monocyte count, platelet count, Hct, blood lactate concentration, blood glucose concentration, serum tumor necrosis factor-α concentration, and plasma thromboxane B2 concentration, were measured. Urine was collected prior to and after experimentation to determine whether nephrotoxicosis was associated with treatment. Results—The treatment group had significantly lower blood lactate concentration and serum tumor necrosis factor-α and plasma thromboxane B2 concentrations and had higher blood glucose concentrations and better attitude scores, compared with the control group, at various time points during the study. No other significant differences and no evidence of overt nephrotoxicosis were detected. Conclusions and Clinical Relevance—Administration of polymyxin B IV in healthy neonatal foals challenged with lipopolysaccharide attenuated some clinical and serum biochemical derangements associated with endotoxemia

Agreement between arterial partial pressure of carbon dioxide and saturation of hemoglobin with oxygen values obtained by direct arterial blood measurements versus noninvasive methods in conscious healthy and ill foals

Objective—To determine agreement between indirect measurements of end-tidal partial pressure of carbon dioxide (Petco2) and saturation of hemoglobin with oxygen as measured by pulse oximetry (Spo2) with direct measurements of Paco2 and calculated saturation of hemoglobin with oxygen in arterial blood (Sao2) in conscious healthy and ill foals. Design—Validation study. Animals—10 healthy and 21 ill neonatal foals. Procedures—Arterial blood gas analysis was performed on healthy and ill foals examined at a veterinary teaching hospital to determine direct measurements of Paco2 and Pao2 along with Sao2. Concurrently, Petco2 was measured with a capnograph inserted into a naris, and Spo2 was measured with a reflectance probe placed at the base of the tail. Paired values were compared by use of Pearson correlation coefficients, and level of agreement was assessed with the Bland-Altman method. Results—Mean ± SD difference between Paco2 and Petco2 was 0.1 ± 5.0 mm Hg. There was significant strong correlation (r = 0.779) and good agreement between Paco2 and Petco2. Mean ± SD difference between Sao2 and Spo2 was 2.5 ± 3.5%. There was significant moderate correlation (r = 0.499) and acceptable agreement between Sao2 and Spo2. Conclusions and Clinical Relevance—Both Petco2 obtained by use of nasal capnography and Spo2 obtained with a reflectance probe are clinically applicable and accurate indirect methods of estimating and monitoring Paco2 and Sao2 in neonatal foals. Indirect methods should not replace periodic direct measurement of corresponding parameters

Nutrition and colony investment in Solenopsis invicta workers

Dissertação de Mestrado em Biologia Celular e Molecular, apresentada ao Departamento de Ciências da Vida Da Faculdade de Ciências e Tecnologia da Universidade de Coimbra.A proteína Tau é responsável pela ligação e estabilização dos microtúbulos (MT) no citoesqueleto, sendo fundamental na função neuronal. A atividade desta proteína pode ser regulada por modificações pós-translacionais, como a fosforilação, que promovem a separação dos microtúbulos. A alteração na conformação da Tau provocada por uma deficiente regulação, como a híper-fosforilação, causa destabilização dos MT e agregação da mesma em filamentos helicoidais emparelhados e tranças neurofibrilares. Estas estruturas são uma das principais características na doença de Alzheimer (AD), e o seu processo de formação pode representar um dos principais motivos que leva a morte celular nas Tauopatias, inclusivamente AD e outras patologias neurodegenerativas. Nos últimos anos, recursos têm sido empregues na descoberta de novas estratégias que permitam diminuir a formação ou diminuam a quantidade de agregados da Tau dentro das células. Estudos recentes identificaram a indução da autofagia através da rapamicina como um dos potenciais alvos no aumento da remoção de agregados proteicos associados a doenças neurodegenerativas, melhorando também a esperança de vida em ratos e outros modelos. Recentemente, o nosso laboratório desenvolveu um modelo celular baseado no trabalho de Guo e Lee (2011) que mimetiza a agregação intracelular da Tau depois de induzida a expressão de uma forma mutada desta proteína seguido do seeding com fibrilas K18:P301L pré-agregadas. Neste estudo, foi possível demonstrar como a utilização destes modelos permite identificar novos compostos com atividade nas vias de redução da Tau. Curiosamente estas moléculas foram responsáveis pelo desenvolvimento de um fenótipo vesicular que identificámos como sendo lisossomas, derivados de um possível estímulo na via endócitica. As alterações na morfologia sub-celular foram acompanhadas por modificações em marcadores de autofagia, sem aumento no fluxo autofágico. Estes dados sugerem que o aumento na degradação de proteínas e estruturas por autofagia poderão ter origem em efeitos colaterais de outras vias em detrimento do estímulo direto. Para além disso, testamos uma série de moléculas com atividade reconhecida e validadas para induzir autofagia ou bloquear a degradação no lisossoma. Foi demonstrado que no nosso modelo, a ativação da autofagia não é responsável pela remoção de agregados. Por outro lado, provámos que os lisossomas são extremamente importantes da degradação de agregados da Tau. Por fim, usámos o fator de transcrição EB (TFEB) para aumentar a biogénese de lisossomas e a autofagia. Células transfectadas com este fator apresentaram menos agregados de Tau e um aumento na viabilidade celular. Quando considerados em conjunto, estes resultados demonstram que a biogénese de lisossomas seguida por estímulos na autofagia podem ser mais importantes do que a ativação da autofagia por si só. Concluindo, com este projeto foi não só possível identificar os mecanismos dos compostos responsáveis pela degradação dos agregados de Tau, como também foi possível validar o TFEB como um potencial novo alvo na descoberta de novos fármacos.Tau protein is responsible for binding and stabilizing microtubules (MT) in the cytoskeleton, thus supporting neuronal function. This protein activity can be regulated by post-translation modifications, such as phosphorylation, which promotes MT detachment. Tau misfolding provoked by abnormal regulation, like hyperphosphorilation, causes MT destabilization and Tau aggregation into paired helical filaments (PHF) and neurofibrillary tangles (NFTs). These structures are one of the main hallmarks in Alzheimer’s disease (AD), and its formation process may represent the principal motive for cell death in many Tauopathies, including AD and other neurodegenerative disorders. Over the last years, great efforts have been placed to find new strategies to either diminish the build-up or decrease the amount of aggregated Tau inside cells. Recent studies have identified induction of autophagy through rapamycin as a potential target in increasing the clearance of aggregated proteins associated with neurodegenerative diseases, as well as ameliorating life expectancy in rats and other animal models. Recently, our lab developed a cellular model based on the work by Guo and Lee (2011) that mimics the intracellular aggregation of Tau after overexpression of a mutated form of this protein and seeding with pre-aggregated K18:P301L fibrils. In this study, we have taken advantage of the developed model to discover new compounds active in Tau reduction pathways. Interestingly these molecules were responsible for the development of a vesicular phenotype that we identified as lysosomes due to a possible stimulation of the endocytic pathway. The change of the sub cellular morphology was followed by changes in autophagy markers, with no increase in the autophagic flux. This suggests an increment in the degradation of proteins and structures by autophagy as a collateral result from the activation of other pathways rather than a direct stimulus. Furthermore, we have tested a series of molecules with known and validated activity to induce autophagy or disable degradation via the lysosome. We showed that at least in our model, autophagy activation is not responsible for the clearance of aggregates. On the other hand, we have proven that lysosomes play a critical role in Tau aggregates degradation. Finally, we have used the transcription factor EB (TFEB) to intensify lysosomal biogenesis and autophagy. Cells transfected with this transcription factor had less Tau aggregates and cell viability was slightly increased. When considered together, these results show that lysosomal biogenesis followed by autophagy stimulation may be more important for clearance of Tau aggregates than autophagy by itself. In conclusion, we have not only determined the mechanisms targeted by the compounds responsible for the degradation of Tau aggregates, but also validated TFEB as a potential new target for drug discovery

Clinical and Immunomodulating Effects of Ketamine in Horses with Experimental Endotoxemia

Background:  Ketamine has immunomodulating effects both in vitro and in vivo during experimental endotoxemia in humans, rodents, and dogs. Hypothesis:  Subanesthetic doses of ketamine will attenuate the clinical and immunologic responses to experimental endotoxemia in horses. Animals:  Nineteen healthy mares of various breeds. Methods:  Experimental study. Horses were randomized into 2 groups: ketamine-treated horses (KET; n = 9) and saline-treated horses (SAL; n = 10). Both groups received 30 ng/kg of lipopolysaccharide (LPS, Escherichia coli, O55:B5) 1 hour after the start of a continuous rate infusion (CRI) of racemic ketamine (KET) or physiologic saline (SAL). Clinical and hematological responses were documented and plasma concentrations of tumor necrosis factor-α (TNF-α) and thromboxane B2 (TXB2) were quantified. Results:  All horses safely completed the study. The KET group exhibited transient excitation during the ketamine loading infusion (P \u3c .05) and 1 hour after discontinuation of administration (P \u3c .05). Neutrophilic leukocytosis was greater in the KET group 8 and 24 hours after administration of LPS (P \u3c .05). Minor perturbations of plasma biochemistry results were considered clinically insignificant. Plasma TNF-α and TXB2 production peaked 1.5 and 1 hours, respectively, after administration of LPS in both groups, but a significant difference between treatment groups was not demonstrated. Conclusions and Clinical Importance:  A subanesthetic ketamine CRI is well tolerated by horses. A significant effect on the clinical or immunologic response to LPS administration, as assessed by clinical observation, hematological parameters, and TNF-α and TXB2production, was not identified in healthy horses with the subanesthetic dose of racemic ketamine utilized in this study

Effect of Carbohydrate Supplementation on Investment into Offspring Number, Size, and Condition in a Social Insect

Resource availability can determine an organism's investment strategies for growth and reproduction. When nutrients are limited, there are potential tradeoffs between investing into offspring number versus individual offspring size. In social insects, colony investment in offspring size and number may shift in response to colony needs and the availability of food resources. We experimentally manipulated the diet of a polymorphic ant species (Solenopsis invicta) to test how access to the carbohydrate and amino acid components of nectar resources affect colony investment in worker number, body size, size distributions, and individual percent fat mass. We reared field-collected colonies on one of four macronutrient treatment supplements: water, amino acids, carbohydrates, and amino acid and carbohydrates. Having access to carbohydrates nearly doubled colony biomass after 60 days. This increase in biomass resulted from an increase in worker number and mean worker size. Access to carbohydrates also altered worker body size distributions. Finally, we found a negative relationship between worker number and size, suggesting a tradeoff in colony investment strategies. This tradeoff was more pronounced for colonies without access to carbohydrate resources. The monopolization of plant-based resources has been implicated in the ecological success of ants. Our results shed light on a possible mechanism for this success, and also have implications for the success of introduced species. In addition to increases in colony size, our results suggest that having access to plant-based carbohydrates can also result in larger workers that may have better individual fighting ability, and that can withstand greater temperature fluctuations and periods of food deprivation

Effects of intravenous administration of polymyxin B in neonatal foals with experimental endotoxemia

Objective—To evaluate the effect of IV administration of polymyxin B on clinical and serum biochemical variables in foals with experimental endotoxemia. Design—Prospective experimental study. Animals—14 healthy neonatal foals. Procedures—Foals were randomly assigned to a treatment or control group and were administered a single dose of lipopolysaccharide (0.5 μg/kg [0.23 μg/lb]) IV over 30 minutes. The treatment group received polymyxin B (6,000 U/kg [2,727 U/lb], IV) immediately after completion of lipopolysaccharide infusion; the control group was administered an equal volume of saline (0.9% NaCl) solution. Subsequent doses of polymyxin B or saline solution were administered IV at 8 and 16 hours. Blood was collected at various time points, and outcome variables, including heart rate, respiratory rate, rectal temperature, attitude score, WBC count, neutrophil count, lymphocyte count, monocyte count, platelet count, Hct, blood lactate concentration, blood glucose concentration, serum tumor necrosis factor-α concentration, and plasma thromboxane B2 concentration, were measured. Urine was collected prior to and after experimentation to determine whether nephrotoxicosis was associated with treatment. Results—The treatment group had significantly lower blood lactate concentration and serum tumor necrosis factor-α and plasma thromboxane B2 concentrations and had higher blood glucose concentrations and better attitude scores, compared with the control group, at various time points during the study. No other significant differences and no evidence of overt nephrotoxicosis were detected. Conclusions and Clinical Relevance—Administration of polymyxin B IV in healthy neonatal foals challenged with lipopolysaccharide attenuated some clinical and serum biochemical derangements associated with endotoxemia.This article is from Journal of the American Veterinary Medical Association 243 (2013): 874, doi: 10.2460/javma.243.6.874. Posted with permission.</p

Renal Replacement Therapy in Healthy Adult Horses

Background Renal replacement therapy (RRT) has been implemented extensively in people to facilitate recovery from acute renal failure (ARF). RRT has not been explored in horses, but might provide a further treatment option in horses with ARF. Objective To investigate efficacy and safety of RRT in horses. Animals Five healthy adult horses. Methods A prospective study was performed on horses restrained in stocks and intravenously connected to a commercial RRT machine to allow continuous venovenous hemodiafiltration to be performed for 6 hours. The RRT machine was set at the following flow rates: blood flow rate 250 mL/min; dialysate rate 3,000 mL/h; prefilter replacement pump 3,000 mL/h; and postfilter replacement pump rate 2,000 mL/h. Balanced electrolyte solution was used as dialysate and replacement fluid. Heart rate, respiratory rate, body temperature, direct arterial blood pressure, urine output, and various clinicopathologic parameters were measured over the study period. Results Renal replacement therapy was successfully performed in horses, resulting in a mean creatinine clearance of 0.127 mL/kg/min (68.9 mL/min) and urea reduction ratio of 24%. No adverse effects were detected although a significant decrease in rectal temperature was observed (P ≤ .007). A significant increase in serum phosphorus (P ≤ .001) and decrease in BUN (P P P P ≤ .04). Conclusions and Clinical Importance Renal replacement therapy can safely and effectively be used in adult horses.This article is from Journal of Veterinary Internal Medicine 27 (2013); 308, doi: 10.1111/jvim.12049. Posted with permission.</p